Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I was honored to participate in ESOC 2026 in Maastricht as part of the industry-sponsored satellite symposium ‘Opportunities for improving AIS patient outcomes’.
My talk, ‘Switching to TNK: the real-world experience’, focused on the implementation of tenecteplase for acute ischemic stroke, including international real-world evidence and early lessons from Argentina.
This transition is an opportunity to revisit hyperacute stroke workflows: simplifying administration, reducing treatment delays, improving transfer logistics, and strengthening local quality monitoring.
I am grateful to Boehringer Ingelheim for the invitation.
It was a privilege to share the Argentine perspective in such an important international forum.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI